These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34169200)

  • 41. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
    Andries G; Karass M; Yandrapalli S; Linder K; Liu D; Nelson J; Pawar R; Chugh S
    Exp Hematol Oncol; 2017; 6():4. PubMed ID: 28101432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab.
    Cammett TJ; Garlo K; Millman EE; Rice K; Toste CM; Faas SJ
    Mol Diagn Ther; 2023 Mar; 27(2):281. PubMed ID: 36870041
    [No Abstract]   [Full Text] [Related]  

  • 43. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
    Nga HS; Palma LMP; Ernandes Neto M; Fernandes-Charpiot IMM; Garcia VD; Kist R; Miranda SMC; Macedo de Souza PA; Pereira GM; de Andrade LGM
    PLoS One; 2021; 16(11):e0258319. PubMed ID: 34748552
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Martin M; Llorens-Cebria C; León-Román J; Perurena-Prieto J; Perez-Beltran V; Saumell S; Torres IB; Agraz I; Sellarès J; Ramos N; Bestard O; López M; Moreso F; Ariceta G; Soler MJ; Hernandez-Gonzalez M; Jacobs-Cachá C
    Kidney Int Rep; 2024 Jul; 9(7):2227-2239. PubMed ID: 39081726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab.
    Ebrahem R; Kadhem S; Truong Q
    Cureus; 2017 Mar; 9(3):e1111. PubMed ID: 28439485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of C5 inhibitors in glomerular diseases in 2021.
    Werion A; Rondeau E
    Kidney Res Clin Pract; 2022 Jul; 41(4):412-421. PubMed ID: 35354244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defining treatment duration in atypical hemolytic uremic syndrome in adults: a clinical and pathological approach.
    Laurence J
    Clin Adv Hematol Oncol; 2020 Apr; 18(4):221-230. PubMed ID: 32628650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury.
    Cao M; Leite BN; Ferreiro T; Calvo M; Fernández C; Alonso Á; Rodriguez A; Salvador P; Seijo R; Pita S; Arjona E; Rodríguez de Córdoba S; Valdés Cañedo F
    Am J Nephrol; 2018; 48(3):225-233. PubMed ID: 30205388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis.
    Fakhouri F; Scully M; Ardissino G; Al-Dakkak I; Miller B; Rondeau E
    J Nephrol; 2021 Oct; 34(5):1581-1590. PubMed ID: 33826112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
    Sridharan M; Go RS; Willrich MAV
    J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A case of atypical hemolytic uremic syndrome successfully treated with eculizumab.
    Thajudeen B; Sussman A; Bracamonte E
    Case Rep Nephrol Urol; 2013 Jul; 3(2):139-46. PubMed ID: 24570684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome.
    Lapeyraque AL; Frémeaux-Bacchi V; Robitaille P
    Pediatr Nephrol; 2011 Apr; 26(4):621-4. PubMed ID: 21161283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features and management of atypical hemolytic uremic syndrome patient with
    Dai X; Ma Y; Lin Q; Tang H; Chen R; Zhu Y; Shen Y; Cui N; Hong Z; Li Y; Li X
    Front Pediatr; 2023; 11():1162974. PubMed ID: 37456562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
    Asif A; Nayer A; Haas CS
    J Nephrol; 2017 Jun; 30(3):347-362. PubMed ID: 27848226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome.
    Vilalta R; Lara E; Madrid A; Chocron S; Muñoz M; Casquero A; Nieto J
    Pediatr Nephrol; 2012 Dec; 27(12):2323-6. PubMed ID: 22890512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
    J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study.
    Lee JW; Sicre de Fontbrune F; Wong Lee Lee L; Pessoa V; Gualandro S; Füreder W; Ptushkin V; Rottinghaus ST; Volles L; Shafner L; Aguzzi R; Pradhan R; Schrezenmeier H; Hill A
    Blood; 2019 Feb; 133(6):530-539. PubMed ID: 30510080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical hemolytic uremic syndrome.
    Afshar-Kharghan V
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):217-225. PubMed ID: 27913483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.